AUPH - Aurinia Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AUPH is currently covered by 1 analysts with an average price target of $20.59. This is a potential upside of $9.04 (78.27%) from yesterday's end of day stock price of $11.55.

Aurinia Pharmaceuticals's activity chart (see below) currently has 113 price targets and 66 ratings on display. The stock rating distribution of AUPH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.75% with an average time for these price targets to be met of 422.25 days.

Highest price target for AUPH is $8, Lowest price target is $8, average price target is $8.

Most recent stock forecast was given by DOUGLAS MIEHM from RBC on 27-Feb-2025. First documented stock forecast 29-Jun-2016.

Currently out of the existing stock ratings of AUPH, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$-3.55 (-30.74%)

$8

7 months 21 days ago
(27-Feb-2025)

9/13 (69.23%)

$0.05 (0.63%)

135

Buy

$13

$1.45 (12.55%)

$13

1 years 1 months 13 days ago
(05-Sep-2024)

13/22 (59.09%)

$5.74 (79.06%)

562

Hold

$6

$-5.55 (-48.05%)

$26

1 years 5 months 17 days ago
(01-May-2024)

3/3 (100%)

$0.83 (16.05%)

398

Hold

$13

2 years 11 months 15 days ago
(03-Nov-2022)

6/9 (66.67%)

$4.73 (57.19%)

359

Buy

$12

$0.45 (3.90%)

$22

2 years 11 months 15 days ago
(03-Nov-2022)

1/4 (25%)

$6.85 (133.01%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?

On average it took 422.25 days on average for the stock forecasts to be realized with a an average price target met ratio 68.75

Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

KEN CACCIATORE

Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?

Alethia Young works at CANTOR FITZGERALD and has 4 price targets and 3 ratings on AUPH

Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?

Ken Cacciatore with highest potential upside - $23.45

Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?

Maury Raycroft with lowest potential downside - -$5.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?